Nano-enabled SERS reporting photosensitizers

Theranostics

Volumn 5, Issue 5, 2015, Pages 469-476

  Farhadi, Arash ^a,b   Roxin, Áron ^a,b   Wilson, Brian C ^a,b   Zheng, Gang ^a,b  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Dosimetry; Nanoparticles; PDT; Porphyrins; SERS; Theranostics

Indexed keywords

LIPOSOME; MANGANESE; METHANOL; NANOPARTICLE; PALLADIUM; PALLADIUM PYROLIPID; PHOTOSENSITIZING AGENT; UNCLASSIFIED DRUG;

ARTICLE; CELL DAMAGE; CELL DEATH; CELL VIABILITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOSIMETRY; DRUG STRUCTURE; FLUORESCENCE ANALYSIS; HUMAN; HUMAN CELL; PHOTODYNAMIC THERAPY; PROCESS MONITORING; PROCESS OPTIMIZATION; RAMAN SPECTROMETRY; FLUORESCENCE IMAGING; LOW LEVEL LASER THERAPY; PHOTOCHEMOTHERAPY; PROCEDURES;

LASER THERAPY; NANOPARTICLES; OPTICAL IMAGING; PALLADIUM; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; SPECTRUM ANALYSIS, RAMAN;

EID: 84930206636     PISSN: None     EISSN: 18387640     Source Type: Journal    
DOI: 10.7150/thno.10694     Document Type: Article

References (30)

1. Lovell JF, Liu TW, Chen J, Zheng G. Activatable photosensitizers for imaging and therapy. Chem Rev 2010; 110: 2839-57.
2. Celli JP, Spring BQ, Rizvi I, Evans CL, Samkoe KS, Verma S, et al. Imaging and photodynamic therapy: mechanisms, monitoring, and optimization. Chem Rev 2010; 110: 2795-838.
3. Davidson SR, Weersink RA, Haider MA, Gertner MR, Bogaards A, Giewercer D, et al. Treatment planning and dose analysis for interstitial photodynamic therapy of prostate cancer. Phys Med Biol 2009; 54: 2293-313.
4. Li J, Altschuler MD, Hahn SM, Zhu TC. Optimization of light source parameters in the photodynamic therapy of heterogeneous prostate. Phys Med Biol 2008; 53: 4107-21.
5. Diamond KR, Patterson MS, Farrell TJ. Quantification of fluorophore concentration in tissue-simulating media by fluorescence measurements with a single optical fiber. Appl Opt 2003; 42: 2436-42.
6. Wilson BC, Patterson MS, Lilge L. Implicit and explicit dosimetry in photodynamic therapy: a new paradigm. Lasers Med Sci 1997; 12: 182-99.
7. Moore CM, Pendse D, Emberton M. Photodynamic therapy for prostate cancer-a review of current status and future promise. Nat Clin Pract Urol 2009; 6: 18-30.
8. Chen CY, Sun E, Fan D, Taniguchi M, McDowell BE, Yang E, et al. Synthesis and physicochemical properties of metallobacteriochlorins. Inorg Chem 2012; 51: 9443-64.
9. Vakrat-Haglili Y, Weiner L, Brumfeld V, Brandis A, Salomon Y, McLlroy B, et al. The microenvironment effect on the generation of reactive oxygen species by Pd-bacteriopheophorbide. J Am Chem Soc 2005; 127: 6487-97.
10. Fukuzumi S, Ohkubo K, Zheng X, Chen Y, Pandey RK, Zhan R, et al. Metal bacteriochlorins which act as dual singlet oxygen and superoxide generators. J Phys Chem B 2008; 112: 2738-46.
11. Jarvi MT, Patterson MS, Wilson BC. Insights into photodynamic therapy dosimetry: simultaneous singlet oxygen luminescence and photosensitizer photobleaching measurements. Biophys J 2012; 102: 661-71.
12. Cottrell WJ, Paquette AD, Keymel KR, Foster TH, Oseroff AR. Irradiance-dependent photobleaching and pain in delta-aminolevulinic acid-photodynamic therapy of superficial basal cell carcinomas. Clin Cancer Res 2008; 14: 4475-83.
13. Tam NC, McVeigh PZ, MacDonald TD, Farhadi A, Wilson BC, Zheng G. Porphyrin-lipid stabilized gold nanoparticles for surface enhanced Raman scattering based imaging. Bioconjug Chem 2012; 23: 1726-30.
14. Lovell JF, Jin CS, Huynh E, Jin H, Kim C, Rubinstein JL, et al. Porphysome nanovesicles generated by porphyrin bilayers for use as multimodal biophotonic contrast agents. Nat Mater 2011; 10: 324-32.
15. Huynh E, Zheng G. Porphysome nanotechnology: A paradigm shift in lipid-based supramolecular structures. Nano Today 2014; 9: 212-22.
16. MacDonald TD, Liu TW, Zheng G. An MRI-sensitive, non-photobleachable porphysome photothermal agent. Angew Chem Int Ed Engl 2014; 53: 6956-9.
17. Gollmer A, Arnbjerg J, Blaikie FH, Pedersen BW, Breitenbach T, Daasbjerg K, et al. Singlet Oxygen Sensor Green: photochemical behavior in solution and in a mammalian cell. Photochem Photobiol 2011; 87: 671-9.
18. Jin CS, Cui L, Wang F, Chen J, Zheng G. Targeting-triggered porphysome nanostructure disruption for activatable photodynamic therapy. Adv Healthc Mater 2014; 3: 1240-9.
19. Chi C, Du Y, Ye J, Kou D, Qiu J, Wang J, et al. Intraoperative Imaging-Guided Cancer Surgery: From Current Fluorescence Molecular Imaging Methods to Future Multi-Modality Imaging Technology. Theranostics 2014; 4: 1072-84.
20. Liu TW, Chen J, Burgess L, Cao W, Shi J, Wilson BC, et al. Multimodal bacteriochlorophyll theranostic agent. Theranostics 2011; 1: 354-62.
21. Shi JY, Liu TWB, Chen J, Green D, Jaffray D, Wilson BC, et al. Transforming a Targeted Porphyrin Theranostic Agent into a PET Imaging Probe for Cancer. Theranostics 2011; 1: 363-70.
22. Lin J, Wang S, Huang P, Wang Z, Chen S, Niu G, et al. Photosensitizer-loaded gold vesicles with strong plasmonic coupling effect for imaging-guided photothermal/photodynamic therapy. ACS Nano 2013; 7: 5320-9.
23. Liu TW, MacDonald TD, Shi J, Wilson BC, Zheng G. Intrinsically copper-64-labeled organic nanoparticles as radiotracers. Angew Chem Int Ed Engl 2012; 51: 13128-31.
24. Liu TW, Stewart JM, Macdonald TD, Chen J, Clarke B, Shi J, et al. Biologically-targeted detection of primary and micro-metastatic ovarian cancer. Theranostics 2013; 3: 420-7.
25. Chen XS. Introducing Theranostics Journal-From the Editor-in-Chief. Theranostics 2011; 1: 1-2.
26. Khaing Oo MK, Yang Y, Hu Y, Gomez M, Du H, Wang H. Gold nanoparticle-enhanced and size-dependent generation of reactive oxygen species from protoporphyrin IX. ACS Nano 2012; 6: 1939-47.
27. Zhang Y, Qian J, Wang D, Wang Y, He S. Multifunctional gold nanorods with ultrahigh stability and tunability for in vivo fluorescence imaging, SERS detection, and photodynamic therapy. Angew Chem Int Ed Engl 2013; 52: 1148-51.
28. McVeigh PZ, Mallia RJ, Veilleux I, Wilson BC. Widefield quantitative multiplex surface enhanced Raman scattering imaging in vivo. J Biomed Opt 2013; 18: 046011.
29. Lecoq J, Parpaleix A, Roussakis E, Ducros M, Goulam Houssen Y, Vinogradov SA, et al. Simultaneous two-photon imaging of oxygen and blood flow in deep cerebral vessels. Nat Med 2011; 17: 893-8.
30. Arian D, Kovbasyuk L, Mokhir A. Control of the photocatalytic activity of bimetallic complexes of pyropheophorbide-a by nucleic acids. Inorg Chem 2011; 50: 12010-7.